Literature DB >> 2313228

Increased turnover of very low density lipoprotein triglyceride during treatment with cholestyramine in familial hypercholesterolaemia.

B Angelin1, B Leijd, R Hultcrantz, K Einarsson.   

Abstract

Kinetics of very low density lipoprotein (VLDL) triglyceride were determined in seven patients with heterozygous familial hypercholesterolaemia, using a 3H-glycerol technique. The study was repeated after 5-7 weeks of therapy with the bile acid-binding resin, cholestyramine. The rate of synthesis of VLDL triglyceride was increased by 85% (P less than 0.05) during resin therapy. Simultaneously, the fractional catabolic rate of VLDL was increased by 40% (P less than 0.02), so that only a moderate increase in plasma concentration was observed. Repeated measurements of VLDL size by electron microscopy (before, 1 week, and 5-7 weeks after initiation of therapy) indicated that a transient increase in VLDL size occurred in response to cholestyramine. The results are consistent with a stimulatory effect of bile acid sequestrants on VLDL triglyceride production and indicate that, in most subjects, a compensatory increase in VLDL triglyceride removal occurs.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2313228     DOI: 10.1111/j.1365-2796.1990.tb00143.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  7 in total

Review 1.  A rational approach to treating hypercholesterolaemia in children. Weighing the risks and benefits.

Authors:  S Tonstad
Journal:  Drug Saf       Date:  1997-05       Impact factor: 5.606

2.  The effects of short term lipid infusion on plasma and hepatic bile lipids in humans.

Authors:  R Pakula; F M Konikoff; A M Moser; F Greif; A Tietz; T Gilat; M Rubin
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

3.  Bile acid sequestrants: mechanisms of action on bile acid and cholesterol metabolism.

Authors:  K Einarsson; S Ericsson; S Ewerth; E Reihnér; M Rudling; D Ståhlberg; B Angelin
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

4.  Apparent selective bile acid malabsorption as a consequence of ileal exclusion: effects on bile acid, cholesterol, and lipoprotein metabolism.

Authors:  J E Akerlund; I Björkhem; B Angelin; L Liljeqvist; K Einarsson
Journal:  Gut       Date:  1994-08       Impact factor: 23.059

5.  Inhibition of intestinal bile acid transporter Slc10a2 improves triglyceride metabolism and normalizes elevated plasma glucose levels in mice.

Authors:  Thomas Lundåsen; Eva-Marie Andersson; Michael Snaith; Helena Lindmark; Johanna Lundberg; Ann-Margret Östlund-Lindqvist; Bo Angelin; Mats Rudling
Journal:  PLoS One       Date:  2012-05-25       Impact factor: 3.240

6.  The association of serum lipids with the histological pattern of rectosigmoid adenoma in Taiwanese adults.

Authors:  Zih-Jie Sun; Ying-Hsiang Huang; Jin-Shang Wu; Yi-Ching Yang; Ying-Fang Chang; Feng-Hwa Lu; Chih-Jen Chang
Journal:  BMC Gastroenterol       Date:  2011-05-15       Impact factor: 3.067

7.  Dietary Mannan Oligosaccharides Modulate Gut Microbiota, Increase Fecal Bile Acid Excretion, and Decrease Plasma Cholesterol and Atherosclerosis Development.

Authors:  Lisa R Hoving; Saeed Katiraei; Marieke Heijink; Amanda Pronk; Lianne van der Wee-Pals; Trea Streefland; Martin Giera; Ko Willems van Dijk; Vanessa van Harmelen
Journal:  Mol Nutr Food Res       Date:  2018-05       Impact factor: 5.914

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.